Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Valeant Pharmaceuticals"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Valeant Pharmaceuticals."

5 result(s) displayed (1 - 5 of 5)


Actavis eyes more acquisitions

Executives say the $8.5 billion purchase of Warner Chilcott will serve as a platform for further growth. Continue reading

Posted on May 21, 2013 9:56 AM




Arbs expect another bump in Obagi battle

Merz Pharma has until Friday to counter a rival bid from Valeant. Continue reading

Posted on April 4, 2013 9:38 AM




This video is exclusive to The Deal Pipeline

PE exit recap: Water Street, KKR lighten portfolios

Check out in-depth details in this recent PE exits recap including Water Street Healthcare-OraPharma, KKR-Alliance Boots and Doughty Hanson-Norit.
Posted on June 25, 2012 12:11 PM



Valeant makes a deal in Russia

The Canadian drugmaker buys Russian specialty pharma company Natur for $180 million. Continue reading

Posted on March 26, 2012 3:48 PM




Biovail and Valeant use advisers both old and new

In merger of equals between Biovail and Valeant Pharmaceuticals, Biovail retains Cravath and Morgan Stanley, while Valeant taps Skadden and Goldman Sachs. Continue reading

Posted on July 2, 2010 10:55 AM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.

Video

Coming back for more

Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video

Sectors